Surgical Devices · Aliso Viejo, CA · Founded 2019 · Publicly Held
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug… SpyGlass Pharma (NAS: SGP) is based in Aliso Viejo, CA and was founded in 2019. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $511 million (Feb 2026). It has raised $349 million across 2 recorded rounds; the latest was a $75 million Series D in Jun 2025.
Last price · $/share
—
Implied valuation
$510.6M
Total raised
$348.5M
Last round
Later Stage VC (Series D)
Jun 2025
No prints on record
No secondary trades in SpyGlass Pharma (NAS: SGP) shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of SpyGlass Pharma (NAS: SGP) with a free account
·Watch SpyGlass Pharma (NAS: SGP): the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of SpyGlass Pharma (NAS: SGP) stock.
